Clinical Trial Update: A Study To Estimate The Effect of PF-06650833 On The Pharmacokinetics (PK) of Oral Contraceptive (OC) [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the effect of PF-06650833 on the pharmacokinetics of oral contraceptives in healthy volunteers; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Individuals

Drugs mentioned

• PF-06650833 (PF-06650833)

Snippet

Sponsor: Pfizer | Conditions: Healthy | Phase 1 | Status: COMPLETED | Results posted: 2023-10-02